Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission

被引：11

作者：

Mischnik, Alexander ^{[1
,2
,11
]}

Baumert, Philipp ^{[1
,2
]}

Hamprecht, Axel ^{[1
,3
]}

Rohde, Anna ^{[1
,4
]}

Peter, Silke ^{[1
,5
]}

Feihl, Susanne ^{[1
,6
]}

Knobloch, Johannes ^{[1
,7
]}

Goelz, Hanna ^{[1
,8
]}

Kola, Axel ^{[1
,4
]}

Obermann, Birgit ^{[1
,9
]}

Querbach, Christiane ^{[1
,6
]}

Willmann, Matthias ^{[1
,5
]}

Gebhardt, Friedemann ^{[1
,6
]}

Tacconelli, Evelina ^{[1
,10
]}

Gastmeier, Petra ^{[1
]}

Seifert, Harald ^{[1
]}

Kern, Winfried V. ^{[1
,2
]}

机构：

[1] German Ctr Infect Res DZIF, Hannover, Germany

[2] Univ Freiburg, Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Freiburg, Germany

[3] Univ Hosp Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany

[4] Chari Univ Hosp Berlin, Natl Reference Ctr Surveillance Nosocomial Infect, Inst Hyg & Environm Med, Berlin, Germany

[5] Univ Tubingen, Inst Med Microbiol & Hygiene, Tubingen, Germany

[6] Tech Univ Munich, Inst Med Microbiol Immunol & Hygiene, Munich, Germany

[7] Univ Hamburg Eppendorf, Inst Med Mikrobiol Virol & Hygiene, Hamburg, Germany

[8] Univ Med Ctr Freiburg, Inst Med Microbiol & Hygiene, Freiburg, Germany

[9] Univ Hosp Schleswig Holstein, Inst Med Microbiol, Lubeck, Germany

[10] Univ Hosp Tubingen, Dept Internal Med 1, Div Infect Dis, Tubingen, Germany

[11] Univ Med Ctr Freiburg, Dept Med, Div Infect Dis, Hugstetter Str 55, D-79106 Freiburg, Germany

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2017年 / 49卷 / 02期

关键词：

Extended-spectrum beta-lactamase; ESBL; beta-Lactam; Avibactam; AmpC; IN-VITRO ACTIVITY; BETA-LACTAMASES; AVIBACTAM; COLONIZATION; CEFTAZIDIME; BACTEREMIA;

D O I：

10.1016/j.ijantimicag.2016.10.013

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

As part of the multicentre Antibiotic Therapy Optimisation Study (ATHOS), minimum inhibitory concentrations (MICs) were determined for cephalosporins alone and in combination with the beta-lactamase inhibitors tazobactam, clavulanic acid and avibactam against third-generation cephalosporin-resistant Escherichia coli, Klebsiella spp. and Enterobacter spp. isolates collected in German hospitals. MIC50/90 values were 0.254mg/L for cefepime/tazobactam, 0.25-2 mg/L for ceftazidime/avibactam, 0.125-0.5mg/L for ceftaroline/avibactam, 0.5-4 mg/L for cefpodoxime/clavulanic acid and 0.25-1 mg/L for aztreonam/avibactam, depending on the underlying resistance mechanism and organism. Based on in vitro testing, beta-lactam antibiotics play an important role in the treatment of infections due to beta-lactamase-producing organisms. (C) 2016 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.

引用

页码：239 / 242

页数：4

共 50 条

[21] Assessment of five screening strategies for optimal detection of carriers of third-generation cephalosporin-resistant Enterobacteriaceae in intensive care units using daily sampling
Grohs, P.
Podglajen, I.
Guerot, E.
Bellenfant, F.
Caumont-Prim, A.
Kac, G.
Tillecovidin, B.
Carbonnelle, E.
Chatellier, G.
Meyer, G.
Fagon, J. Y.
Gutmann, L.
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (11) : O879 - O886
[22] An International Prospective Cohort Study To Validate 2 Prediction Rules for Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales
Deelen, J. W. Timoteus
Rottier, Wouter C.
Ortega, Jose A. Giron
Rodriguez-Bano, Jesus
Harbarth, Stephan
Tacconelli, Evelina
Jacobsson, Gunnar
Zahar, Jean-Ralph
van Werkhoven, Cornelis H.
Bonten, Marc J. M.
CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E4475 - E4483
[23] Gut microbiota compositions in the carriers and noncarriers of third-generation cephalosporin-resistant Escherichia coli: A study among children in southern Taiwan
Yang, Keng-Chin
Tien, Wan-Yu
Cheng, Ming-Fang
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2024, 57 (06) : 896 - 905
[24] In Vitro Activity and Clinical Efficacy of Faropenem against Third-Generation Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae
Ishikawa, Kazuhiro
Uehara, Yuki
Mori, Nobuyoshi
Mikami, Yumiko
Tokioka, Sayuri
Kobayashi, Daiki
Goke, Hisa
Inukai, Tatsuya
Sakurai, Aki
Doi, Yohei
Kawakami, Sayoko
Kayama, Shizuo
Sugai, Motoyuki
Nakamura, Shigeki
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (06)
[25] Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features
Courpon-Claudinon, A.
Lefort, A.
Panhard, X.
Clermont, O.
Dornic, Q.
Fantin, B.
Mentre, F.
Wolff, M.
Denamur, E.
Branger, C.
CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (04) : 557 - 565
[26] Genomic epidemiology of third-generation cephalosporin-resistant Escherichia coli from companion animals and human infections in Europe
Biguenet, Adrien
Valot, Benoit
El Garch, Farid
Bertrand, Xavier
Hocquet, Didier
ONE HEALTH, 2025, 20
[27] Clinical characteristics of bacteremic urinary tract infection due to third-generation cephalosporin-resistant Escherichia coli in children
Hashimoto, Risa
Shoji, Kensuke
Ishiguro, Akira
Miyairi, Isao
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (03) : 469 - 471
[28] Extended-Spectrum beta-Lactamase-Producing and Third-Generation Cephalosporin-Resistant Enterobacteriaceae in Children: Trends in the United States, 1999-2011
Logan, Latania K.
Braykov, Nikolay P.
Weinstein, Robert A.
Laxminarayan, Ramanan
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2014, 3 (04) : 320 - 328
[29] Prevalence and characterisation of third-generation cephalosporin-resistant Shigella flexneri isolates from Jiangsu Province, China, 2013-2015
Liu, Guoye
Qian, Huimin
Tang, Bo
Chen, Yin
Kang, Haiquan
Jiang, Fei
Ma, Ping
Gu, Bing
Huo, Xiang
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2018, 15 : 283 - 287
[30] The in vitro activity of sulbactam combined with third generation cephalosporins against third generation cephalosporin-resistant bacteria
Zhang, YL
Li, JT
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 17 (02) : 143 - 146

← 1 2 3 4 5 →